BRASH Syndrome: A Critical Intersection of Bradycardia, Renal Failure, AV-Node Blockade, Shock, and Hyperkalemia in Clinical Practice

Main Article Content

Donaldo Emiliano Silva López
Andres Gerardo Herrera Jimenez
Jesús Benjamín Díaz Sánchez
Maria Fernanda Mireles Ortega
Isidro Fabián Martínez Valeriano
María Guadalupe Gómez Moreno

Abstract

BRASH syndrome is an underrecognized yet potentially life-threatening clinical entity characterized by the interplay of bradycardia, renal failure, AV-node blockade, shock, and hyperkalemia. This syndrome represents a complex feedback loop where the synergistic effects of hyperkalemia and atrioventricular nodal blocking agents precipitate severe bradycardia, exacerbating renal perfusion and resulting in acute kidney injury. This further amplifies hyperkalemia, perpetuating a vicious cycle that can culminate in cardiogenic shock and multiorgan dysfunction.


Despite its significance, BRASH syndrome is often misdiagnosed as isolated hyperkalemia or primary heart block, leading to delays in appropriate management. Early recognition and a systematic approach to its pathophysiology are essential for targeted treatment. The present review synthesizes current knowledge on the pathogenesis, diagnostic criteria, and evidence-based management strategies for BRASH syndrome, emphasizing the importance of tailored therapeutic interventions to break the cycle of deterioration. Additionally, we discuss emerging insights into its pathophysiology and highlight gaps in the literature requiring further investigation.

Article Details

How to Cite
Donaldo Emiliano Silva López, Andres Gerardo Herrera Jimenez, Jesús Benjamín Díaz Sánchez, Maria Fernanda Mireles Ortega, Isidro Fabián Martínez Valeriano, & María Guadalupe Gómez Moreno. (2024). BRASH Syndrome: A Critical Intersection of Bradycardia, Renal Failure, AV-Node Blockade, Shock, and Hyperkalemia in Clinical Practice. International Journal of Medical Science and Clinical Research Studies, 4(12), 2400–2405. https://doi.org/10.47191/ijmscrs/v4-i12-51
Section
Articles

References

I. Farkas JD, Long B, Koyfman A, Menson K. BRASH Syndrome: Bradycardia, Renal Failure, AV Blockade, Shock, and Hyperkalemia. J Emerg

Med. 2020 Aug;59(2):216–23.

II. Schnaubelt S, Roeggla M, Spiel AO, Schukro C, Domanovits H. The BRASH syndrome: an interaction of bradycardia, renal failure, AV block,

shock and hyperkalemia. Intern Emerg Med. 2021 Mar;16(2):509–11.

III. Halli-Tierney A, Scarbrough C, Carroll DG. Polypharmacy: Evaluating Risks and Deprescribing. Am Fam Physician. 2019 Jul 1;100(1):32–8.

IV. Ravioli S, Woitok BK, Lindner G. BRASH syndrome – fact or fiction? A first analysis of the prevalence and relevance of a newly describedsyndrome. Eur J Emerg Med. 2021 Apr;28(2):153–5.

V. Lizyness K, Dewald O. BRASH Syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021. Available from: http://www.ncbi.nlm.nih.gov/books/NBK570643/

VI. Sarkar S, Rapista N, Rout A, Chaudhary R. BRASH: Case Report and Review of Literature. Hearts. 2021 Jun 27;2(3):302–6.

VII. Srivastava S, Kemnic T, Hildebrandt KR. BRASH syndrome. BMJ Case Rep. 2020 Feb;13(2):e233825.

VIII. Prabhu V, Hsu E, Lestin S, Soltanianzadeh Y, Hadi S. Bradycardia, Renal Failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia (BRASH) Syndrome as a Presentation of Coronavirus Disease 2019. Cureus [Internet]. 2020 Apr 24 Available from: https://www.cureus.com/articles/31127- bradycardia-renal-failure-atrioventricular-nodal- blockade-shock-and-hyperkalemia-brash- Syndrome-as-a-presentation-of-coronavirus- disease-2019

IX. Grigorov MV, Belur AD, Otero D, Chaudhary S, Grigorov E, Ghafghazi S. The BRASH syndrome, a synergistic arrhythmia phenomenon. Bayl Univ

Med Cent Proc. 2020 Oct 1;33(4):668–70.

X. Wong C, Jaafar M. Bradycardia, renal failure, atrioventricular nodal blockade, shock, and hyperkalemia: An important syndrome to recognize. Turk J Emerg Med. 2021;21(2):86.

XI. Nagamine T. BRASH syndrome associated with angiotensin receptor blocker and SGLT2 inhibitor. Can J Emerg Med [Internet]. 2021 Oct 1; Available from: https://link.springer.com/10.1007/s43678-021- 00213-9

XII. Ata F, yasir M, Javed S, Bilal ABI, Muthanna B, Minhas B, et al. Diagnostic and therapeutic challenges of BRASH syndrome: A case report.

Med Case Rep Study Protoc. 2021 Jan;2(1):e0018.

XIII. Diribe N, Le J. Trimethoprim/Sulfamethoxazole- Induced Bradycardia, Renal Failure, AV-Node Blockers, Shock and Hyperkalemia Syndrome. Clin Pract Cases Emerg Med. 2019 Jul 22;3(3):282–5.

XIV. Flores S. Anaphylaxis induced bradycardia, renal failure, AV-nodal blockade, shock, and hyperkalemia: A-BRASH in the emergency department. Am J Emerg Med. 2020 Sep;38(9):1987.e1-1987.e3.

XV. Sattar Y, Bareeqa SB, Rauf H, Ullah W, Alraies MC. Bradycardia, Renal Failure, Atrioventricular- nodal Blocker, Shock, and Hyperkalemia Syndrome Diagnosis and Literature Review. Cureus [Internet]. 2020 Feb 13 Available from: https://www.cureus.com/articles/27877- bradycardia-renal-failure-atrioventricular-nodal- blocker-shock-and-hyperkalemia-syndrome- diagnosis-and-literature-review

Most read articles by the same author(s)

<< < 1 2 3 > >>